查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2066045

感染疾病監測解決方案市場：按組件、技術、監測的感染疾病類型、部署模式、應用和最終用戶分類－2026-2032年全球市場預測

Infection Surveillance Solution Market by Component, Technology, Infection Type Monitored, Deployment Mode, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 180 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，感染疾病監測解決方案市場將成長至 2,442,920,000 美元，複合年成長率為 14.00%。

主要市場統計數據
基準年 2025 9.7581億美元
預計年份：2026年 1,097,240,000 美元
預測年份 2032 2,442,920,000 美元
複合年成長率 (%) 14.00%

隨著醫療系統努力應對醫療相關感染疾病、抗生素抗藥性和新興病原體等問題，感染監測解決方案正成為醫院、實驗室、長期照護機構和公共衛生機構的核心基礎設施。根據世界衛生組織統計，高所得國家每100名患者中有7名，中低收入國家每100名患者中有15名在急性照護期間至少發生一次醫療相關感染疾病。同時，美國疾病管制與預防中心估計，美國每天約有1/31的住院患者至少發生一次醫療相關感染疾病。

最新的感染監測平台整合了電子健康記錄、實驗室資訊系統、藥物數據、入院、出院和轉院資訊、微生物檢測結果以及病例報告工作流程，以加快感染的發現、調查和預防。市場對自動化感染預防軟體、集體爆發監測、抗菌藥物使用分析以及可互通的報告工具​​的需求日益成長，這些工具能夠減少人工病歷審查，加強監管合規性，並提升患者安全保障。

感染監測領域的變革性變化

感染監測正從被動的合規性報告轉向持續的、數據驅動的預防。醫療機構正在用自動化監測引擎取代基於電子表格的感染追蹤方式，這些引擎能夠識別叢集感染、標記多重抗藥性細菌、監測醫療設備相關感染疾病，並支持在住院、門診和社區醫療機構中及時採取乾預措施。

人工智慧的累積影響

人工智慧透過改善早期訊號檢測、風險分層和工作量優先排序，提升了感染監測的價值。機器學習模型可以分析微生物檢測結果、抗生素處方、醫療設備使用情況、病患流動情況和臨床記錄，從而識別人工審核中可能被忽略的模式。自然語言處理技術正被擴大用於從非結構化臨床文件（例如病程記錄、放射學報告和出院小結）中提取與感染相關的背景資訊。

按地區分類的主要見解

北美地區仍然是傳染病監測解決方案應用的領先地區，這得益於其較高的電子健康記錄(EHR) 普及率、美國疾病控制與預防中心 (CDC) 的國家醫院監測網路 (NHSN) 報告要求、強制性合理使用感染疾病以及對醫院質量改進的積極投入。歐洲受益於歐洲疾病預防控制中心 (ECDC)主導的監測網路、國家感染控制計劃以及歐盟 (EU) 的數位健康互通性優先事項，其需求主要集中在標準化報告、符合隱私規定的分析以及跨境應對措施上。亞太地區正在快速發展，中國、印度、日本、韓國、澳洲和東南亞國協的醫療保健系統正在推動醫院數位化、檢查室現代化以及對感染疾病控制的投入。

關鍵的群體特定見解

東南亞國協正透過醫院認證、區域疾病監測和投資數位醫療基礎設施來加強感染監測，具體實施方案因電子健康記錄（EHR）的成熟度和檢查室連接性而異。海灣合作理事會（GCC）國家正在建立技術驅動型醫療保健系統，具備先進的緊急應變能力，基於雲端的感染預防平台、疫情儀表板和抗菌藥物管理工具在公立和私立醫院中日益重要。歐盟強調跨境資料標準、隱私合規和協作式感染疾病監測，因此需要支援國家和地區報告框架的、互通性且符合GDPR的平台。

主要國家的概況

在美國，需求主要受美國疾病管制與預防中心 (CDC) 參與國家醫療保健安全網路 (NHSN)、品質報告、抗菌藥物管理要求以及醫院資訊科技生態系統的整合所驅動；而在加拿大，重點在於省級監測、病患安全和協調一致的感染預防計畫。在墨西哥和巴西，隨著醫療保健現代化進程的加快、認證系統的改善以及公共衛生報告需求的增加，醫院感染控制計畫正在加強。在歐洲，英國、德國、法國、義大利和西班牙優先考慮標準化報告、感染預防績效以及符合隱私規定的資料交換；而在俄羅斯，對大規模區域醫療保健系統和集中式公共衛生機制的感染疾病監測需求仍然存在。

為行業領導者提供的實用建議

產業領導者應優先考慮可互通的感染監測平台，這些平台應整合電子健康記錄(EHR)、實驗室服務、藥物、床位管理、醫療設備使用情況和公共衛生報告系統。解決方案應支援經認證的定義、可設定的規則、即時警報、基於角色的儀表板和可審計的工作流程，從而幫助感染預防團隊從被動監測轉向主動干預。

調查方法

本執行摘要基於結構化的研究途徑，結合了二手資料研究、專家解讀和證據三角檢驗。資訊來源包括世界衛生組織、美國疾病管制與預防中心、歐洲疾病預防控制中心和各國衛生署發布的指南和資料集、同行評審的感染預防文獻、醫院品質報告框架、數位衛生政策文件以及抗菌素抗藥性監測計畫。

結論

感染監測解決方案正從單純的管理工具發展成為保障病人安全、應對抗菌藥物抗藥性和提升醫療系統韌性的策略平台。最有效的解決方案融合了自動化、互通性、臨床管理的AI、安全的數據交換和可操作的分析，從而為感染預防團隊提供即時支援。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 市場進入策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章：感染疾病監測解決方案市場：依組件分類

  • 服務
    • 諮詢
    • 實施與整合
    • 維護和升級
    • 培訓和支持
  • 軟體
    • 警報管理
    • 資料分析
    • 報告創建和可視化

第8章：感染疾病監測解決方案市場：依技術分類

  • 人工智慧和機器學習
    • 監督式學習
    • 無監督學習
  • 基於物聯網和感測器的
  • 傳統規則型

第9章：感染疾病監測解決方案市場：依監測的感染疾病類型分類

  • 血液感染疾病
  • 術後感染
  • 尿道感染
  • 胃腸道感染疾病
  • 呼吸道感染疾病
  • 醫療設備相關感染疾病
  • 多重抗藥性細菌病菌感染

第10章：感染疾病監測解決方案市場：依部署模式分類

  • 雲
    • 混合雲端
    • 私有雲端
    • 公共雲端
  • 現場
    • 專用伺服器
    • 虛擬化

第11章：感染疾病監測解決方案市場：按應用領域分類

  • 感染控制和院內感染（HAI）監測
    • 血液感染疾病
    • 手術部位感染
    • 尿道感染
  • 感染控制
    • 病例識別
    • 接觸者追蹤
    • 資源分配
  • 病原體基因組分析
  • 基於症候群的監測

第12章：感染疾病監測解決方案市場：依最終用戶分類

  • 診斷實驗室
  • 醫院
  • 公共衛生組織
  • 研究機構

第13章：感染疾病監測解決方案市場：按地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第14章：感染疾病監測解決方案市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章：感染疾病監測解決方案市場：按國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第17章：公司簡介

  • Abbott Laboratories
  • Alcidion Group Limited
  • Ascom Holding AG
  • Baxter International Inc.
  • Becton, Dickinson and Company
  • bioMerieux SA
  • BioVigil Healthcare Systems, Inc.
  • Ecolab Inc.
  • Environmental Systems Research Institute, Inc.
  • Epic Systems Corporation
  • Getinge AB
  • GOJO Industries, Inc.
  • HealthConnex
  • InductiveHealth Informatics
  • Inovalon, Inc.
  • InterSystems Corporation
  • Juvare, LLC
  • Koninklijke Philips NV
  • Medical Information Technology, Inc.
  • Medtronic plc
  • Midmark Corporation
  • Nosotech
  • Oracle Corporation
  • Palantir Technologies Inc.
  • PointClickCare Technologies Inc.
  • RLDatix
  • SafeQual Health, LP
  • SAS Institute Inc.
  • STERIS plc
  • sterloCare
  • SwipeSense, Inc.
  • Vitalacy, Inc.
  • Wolters Kluwer NV
  • ZulaFly, Inc.
Product Code: MRR-43127F727969

The Infection Surveillance Solution Market is projected to grow by USD 2,442.92 million at a CAGR of 14.00% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 975.81 million
Estimated Year [2026] USD 1,097.24 million
Forecast Year [2032] USD 2,442.92 million
CAGR (%) 14.00%

Infection surveillance solutions are becoming core infrastructure for hospitals, laboratories, long-term care facilities, and public health agencies as healthcare systems respond to healthcare-associated infections, antimicrobial resistance, and emerging pathogens. The WHO reports that 7 in 100 patients in high-income countries and 15 in 100 patients in low- and middle-income countries acquire at least one healthcare-associated infection during acute care, while the CDC estimates that about 1 in 31 U.S. hospital patients has at least one healthcare-associated infection on any given day.

Modern infection surveillance platforms integrate electronic health records, laboratory information systems, pharmacy data, admission-discharge-transfer feeds, microbiology results, and case reporting workflows to accelerate detection, investigation, and prevention. Demand is rising for automated infection prevention software, real-time outbreak monitoring, antimicrobial stewardship analytics, and interoperable reporting tools that reduce manual chart review, improve regulatory readiness, and strengthen patient safety programs.

Transformative Shifts in the Infection Surveillance Landscape

The infection surveillance landscape is shifting from retrospective compliance reporting to continuous, data-driven prevention. Healthcare organizations are replacing spreadsheet-based infection tracking with automated surveillance engines that identify clusters, flag multidrug-resistant organisms, monitor device-associated infections, and support timely interventions across inpatient, outpatient, and community settings.

Regulatory pressure and global preparedness priorities are also reshaping adoption. CDC NHSN reporting, ECDC HAI-Net surveillance, WHO GLASS antimicrobial resistance monitoring, and national digital health programs are encouraging standardized definitions, interoperable data exchange, and auditable infection prevention workflows. At the same time, cloud deployment, API-based integration, data quality management, and cybersecurity-by-design are becoming essential buying criteria for healthcare IT leaders.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is expanding the value of infection surveillance by improving early signal detection, risk stratification, and workload prioritization. Machine learning models can analyze microbiology results, antibiotic orders, device utilization, patient movement, and clinical notes to identify patterns that may be missed during manual review. Natural language processing is increasingly used to extract infection-relevant context from unstructured clinical documentation, including progress notes, radiology narratives, and discharge summaries.

The cumulative impact of AI is strongest when algorithms are clinically validated, explainable, and embedded into infection prevention workflows. AI-enabled surveillance can support faster outbreak recognition, more targeted isolation precautions, better antimicrobial stewardship, and more consistent reporting, but implementation requires strong data governance, bias monitoring, privacy controls, cybersecurity safeguards, and human oversight to ensure patient safety and regulatory trust.

Key Regional Insights

North America remains a leading region for infection surveillance solution adoption, supported by mature EHR penetration, CDC NHSN reporting requirements, antimicrobial stewardship mandates, and strong investment in hospital quality improvement. Europe benefits from ECDC-led surveillance networks, national infection control programs, and European Union digital health interoperability priorities, with demand concentrated around standardized reporting, privacy-compliant analytics, and cross-border preparedness. Asia-Pacific is expanding rapidly as China, India, Japan, South Korea, Australia, and ASEAN health systems invest in hospital digitization, laboratory modernization, and infectious disease preparedness.

Latin America shows growing demand in Brazil and Mexico as private hospital networks and public health agencies strengthen infection control capacity, antimicrobial resistance monitoring, and accreditation-driven quality programs. The Middle East, particularly GCC markets, is adopting advanced surveillance across smart hospitals and digitally connected health systems, with emphasis on rapid outbreak detection and centralized dashboards. Africa is prioritizing scalable, laboratory-linked surveillance to address outbreak response, antimicrobial resistance, and resource-constrained infection prevention, supported by regional public health initiatives and investments in disease monitoring infrastructure.

Key Group Insights

ASEAN countries are strengthening infection surveillance through hospital accreditation, regional disease monitoring, and investments in digital health infrastructure, with adoption shaped by varying levels of EHR maturity and laboratory connectivity. The GCC is advancing high-acuity, technology-enabled healthcare systems, making cloud-based infection prevention platforms, outbreak dashboards, and antimicrobial stewardship tools increasingly relevant for public and private hospitals. The European Union emphasizes cross-border data standards, privacy compliance, and coordinated infection monitoring, creating demand for interoperable and GDPR-aligned platforms that support national and regional reporting frameworks.

BRICS countries represent high-volume opportunities due to large patient populations, expanding hospital networks, and rising antimicrobial resistance surveillance needs across complex public and private care systems. G7 markets lead in advanced analytics, regulatory reporting, clinical validation, and integrated quality improvement, supporting adoption of automated infection surveillance software and AI-enabled decision support. NATO members increasingly view infectious disease surveillance as part of health security, resilience planning, military medical readiness, and emergency preparedness, reinforcing the need for secure, interoperable, and rapidly deployable surveillance systems.

Key Country Insights

The United States leads demand through CDC NHSN participation, quality reporting, antimicrobial stewardship requirements, and integrated hospital IT ecosystems, while Canada emphasizes provincial surveillance, patient safety, and coordinated infection prevention programs. Mexico and Brazil are strengthening hospital infection control programs as healthcare modernization, accreditation, and public health reporting needs accelerate. In Europe, the United Kingdom, Germany, France, Italy, and Spain prioritize standardized reporting, infection prevention performance, and privacy-compliant data exchange, while Russia maintains demand for infectious disease monitoring across large regional health systems and centralized public health structures.

China and India represent major growth markets due to large hospital networks, rising digital health investment, laboratory expansion, and heightened focus on antimicrobial resistance. Japan, South Korea, and Australia show strong readiness for AI-enabled surveillance due to advanced health IT adoption, aging populations, mature infection control frameworks, and established public health reporting practices. Across these countries, procurement decisions increasingly center on interoperability, clinical validation, automation, cybersecurity, regulatory alignment, and measurable reduction in infection prevention workload.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize interoperable infection surveillance platforms that connect EHR, laboratory, pharmacy, bed management, device utilization, and public health reporting systems. Solutions should support recognized definitions, configurable rules, real-time alerts, role-based dashboards, and auditable workflows that help infection prevention teams move from passive monitoring to proactive intervention.

Vendors and providers should invest in AI governance, cybersecurity, data quality, and clinical validation before scaling predictive analytics. Leaders can strengthen adoption by aligning surveillance programs with antimicrobial stewardship, quality improvement, accreditation, and emergency preparedness goals. Clear ROI measurement should include reduced manual review time, faster outbreak detection, improved reporting accuracy, better targeting of prevention resources, and stronger readiness for regulatory audits.

Research Methodology

This executive summary is based on a structured research approach combining secondary research, expert interpretation, and evidence triangulation. Sources include publicly available guidance and datasets from the WHO, CDC, ECDC, national health ministries, peer-reviewed infection prevention literature, hospital quality reporting frameworks, digital health policy documents, and antimicrobial resistance surveillance programs.

The methodology evaluates demand drivers, regulatory requirements, technology adoption, regional healthcare infrastructure, interoperability readiness, and procurement priorities. Findings are validated by comparing global health indicators, surveillance frameworks, hospital digitization trends, infection prevention standards, and public health reporting requirements across regions, groups, and key countries to ensure evidence-led insights for infection surveillance solutions.

Conclusion

Infection surveillance solutions are moving from administrative tools to strategic platforms for patient safety, antimicrobial resistance control, and health system resilience. The most effective solutions combine automation, interoperability, clinically governed AI, secure data exchange, and actionable analytics to support infection prevention teams in real time.

As healthcare systems face persistent healthcare-associated infections and recurring infectious disease threats, demand will continue to shift toward scalable, secure, and evidence-based surveillance platforms. Organizations that invest early in integrated infection prevention intelligence will be better positioned to improve outcomes, meet reporting obligations, reduce preventable risk, and strengthen preparedness.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Infection Surveillance Solution Market, by Component

  • 7.1. Services
    • 7.1.1. Consulting
    • 7.1.2. Implementation & Integration
    • 7.1.3. Maintenance & Upgrades
    • 7.1.4. Training & Support
  • 7.2. Software
    • 7.2.1. Alert Management
    • 7.2.2. Data Analytics
    • 7.2.3. Reporting & Visualization

8. Infection Surveillance Solution Market, by Technology

  • 8.1. Artificial Intelligence And Machine Learning
    • 8.1.1. Supervised Learning
    • 8.1.2. Unsupervised Learning
  • 8.2. Internet Of Things And Sensor Based
  • 8.3. Traditional Rule Based

9. Infection Surveillance Solution Market, by Infection Type Monitored

  • 9.1. Bloodstream Infections
  • 9.2. Surgical Site Infections
  • 9.3. Urinary Tract Infections
  • 9.4. Gastrointestinal Infections
  • 9.5. Respiratory Infections
  • 9.6. Device-Associated Infections
  • 9.7. Multidrug-Resistant Organism Infections

10. Infection Surveillance Solution Market, by Deployment Mode

  • 10.1. Cloud
    • 10.1.1. Hybrid Cloud
    • 10.1.2. Private Cloud
    • 10.1.3. Public Cloud
  • 10.2. On Premises
    • 10.2.1. Dedicated Servers
    • 10.2.2. Virtualization

11. Infection Surveillance Solution Market, by Application

  • 11.1. Infection Control & HAI Surveillance
    • 11.1.1. Bloodstream Infections
    • 11.1.2. Surgical Site Infections
    • 11.1.3. Urinary Tract Infections
  • 11.2. Outbreak Management
    • 11.2.1. Case Identification
    • 11.2.2. Contact Tracing
    • 11.2.3. Resource Allocation
  • 11.3. Pathogen Genomics Analysis
  • 11.4. Syndromic Surveillance

12. Infection Surveillance Solution Market, by End User

  • 12.1. Diagnostic Labs
  • 12.2. Hospitals
  • 12.3. Public Health Agencies
  • 12.4. Research Institutes

13. Infection Surveillance Solution Market, by Region

  • 13.1. Asia-Pacific
  • 13.2. North America
  • 13.3. Latin America
  • 13.4. Europe
  • 13.5. Middle East
  • 13.6. Africa

14. Infection Surveillance Solution Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Infection Surveillance Solution Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Concentration Analysis, 2025
    • 16.1.1. Concentration Ratio (CR)
    • 16.1.2. Herfindahl Hirschman Index (HHI)
  • 16.2. Recent Developments & Impact Analysis, 2025
  • 16.3. Product Portfolio Analysis, 2025
  • 16.4. Benchmarking Analysis, 2025

17. Company Profiles

  • 17.1. Abbott Laboratories
  • 17.2. Alcidion Group Limited
  • 17.3. Ascom Holding AG
  • 17.4. Baxter International Inc.
  • 17.5. Becton, Dickinson and Company
  • 17.6. bioMerieux SA
  • 17.7. BioVigil Healthcare Systems, Inc.
  • 17.8. Ecolab Inc.
  • 17.9. Environmental Systems Research Institute, Inc.
  • 17.10. Epic Systems Corporation
  • 17.11. Getinge AB
  • 17.12. GOJO Industries, Inc.
  • 17.13. HealthConnex
  • 17.14. InductiveHealth Informatics
  • 17.15. Inovalon, Inc.
  • 17.16. InterSystems Corporation
  • 17.17. Juvare, LLC
  • 17.18. Koninklijke Philips N.V.
  • 17.19. Medical Information Technology, Inc.
  • 17.20. Medtronic plc
  • 17.21. Midmark Corporation
  • 17.22. Nosotech
  • 17.23. Oracle Corporation
  • 17.24. Palantir Technologies Inc.
  • 17.25. PointClickCare Technologies Inc.
  • 17.26. RLDatix
  • 17.27. SafeQual Health, L.P.
  • 17.28. SAS Institute Inc.
  • 17.29. STERIS plc
  • 17.30. sterloCare
  • 17.31. SwipeSense, Inc.
  • 17.32. Vitalacy, Inc.
  • 17.33. Wolters Kluwer N.V.
  • 17.34. ZulaFly, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 7. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 8. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY COMPONENT, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY COMPONENT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY TECHNOLOGY, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY INFECTION TYPE MONITORED, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY INFECTION TYPE MONITORED, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END USER, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 22. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 23. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 24. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 25. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL SERVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL SERVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL CONSULTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL CONSULTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL CONSULTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL IMPLEMENTATION & INTEGRATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL IMPLEMENTATION & INTEGRATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL IMPLEMENTATION & INTEGRATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL MAINTENANCE & UPGRADES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL MAINTENANCE & UPGRADES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL MAINTENANCE & UPGRADES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL TRAINING & SUPPORT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL TRAINING & SUPPORT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL TRAINING & SUPPORT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL SOFTWARE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL SOFTWARE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL SOFTWARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL ALERT MANAGEMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL ALERT MANAGEMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL ALERT MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL DATA ANALYTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL DATA ANALYTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL DATA ANALYTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL REPORTING & VISUALIZATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL REPORTING & VISUALIZATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL REPORTING & VISUALIZATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL ARTIFICIAL INTELLIGENCE AND MACHINE LEARNING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL ARTIFICIAL INTELLIGENCE AND MACHINE LEARNING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL ARTIFICIAL INTELLIGENCE AND MACHINE LEARNING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL SUPERVISED LEARNING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL SUPERVISED LEARNING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL SUPERVISED LEARNING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL UNSUPERVISED LEARNING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL UNSUPERVISED LEARNING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL UNSUPERVISED LEARNING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL INTERNET OF THINGS AND SENSOR BASED MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL INTERNET OF THINGS AND SENSOR BASED MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL INTERNET OF THINGS AND SENSOR BASED MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL TRADITIONAL RULE BASED MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL TRADITIONAL RULE BASED MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL TRADITIONAL RULE BASED MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY INFECTION TYPE MONITORED, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL BLOODSTREAM INFECTIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL BLOODSTREAM INFECTIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL BLOODSTREAM INFECTIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL SURGICAL SITE INFECTIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL SURGICAL SITE INFECTIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL SURGICAL SITE INFECTIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL URINARY TRACT INFECTIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL URINARY TRACT INFECTIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL URINARY TRACT INFECTIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL GASTROINTESTINAL INFECTIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL GASTROINTESTINAL INFECTIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL GASTROINTESTINAL INFECTIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL RESPIRATORY INFECTIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL RESPIRATORY INFECTIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL RESPIRATORY INFECTIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL DEVICE-ASSOCIATED INFECTIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL DEVICE-ASSOCIATED INFECTIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL DEVICE-ASSOCIATED INFECTIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL MULTIDRUG-RESISTANT ORGANISM INFECTIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL MULTIDRUG-RESISTANT ORGANISM INFECTIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL MULTIDRUG-RESISTANT ORGANISM INFECTIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL CLOUD MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL CLOUD MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL CLOUD MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL HYBRID CLOUD MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL HYBRID CLOUD MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL HYBRID CLOUD MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL PRIVATE CLOUD MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL PRIVATE CLOUD MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL PRIVATE CLOUD MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL PUBLIC CLOUD MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL PUBLIC CLOUD MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL PUBLIC CLOUD MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL ON PREMISES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL ON PREMISES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL ON PREMISES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL DEDICATED SERVERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL DEDICATED SERVERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL DEDICATED SERVERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL VIRTUALIZATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL VIRTUALIZATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL VIRTUALIZATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL INFECTION CONTROL & HAI SURVEILLANCE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL INFECTION CONTROL & HAI SURVEILLANCE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL INFECTION CONTROL & HAI SURVEILLANCE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL BLOODSTREAM INFECTIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL BLOODSTREAM INFECTIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL BLOODSTREAM INFECTIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL SURGICAL SITE INFECTIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL SURGICAL SITE INFECTIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL SURGICAL SITE INFECTIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL URINARY TRACT INFECTIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL URINARY TRACT INFECTIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL URINARY TRACT INFECTIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL OUTBREAK MANAGEMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL OUTBREAK MANAGEMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL OUTBREAK MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL CASE IDENTIFICATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL CASE IDENTIFICATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL CASE IDENTIFICATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL CONTACT TRACING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL CONTACT TRACING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL CONTACT TRACING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL RESOURCE ALLOCATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL RESOURCE ALLOCATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL RESOURCE ALLOCATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL PATHOGEN GENOMICS ANALYSIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL PATHOGEN GENOMICS ANALYSIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL PATHOGEN GENOMICS ANALYSIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL SYNDROMIC SURVEILLANCE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL SYNDROMIC SURVEILLANCE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL SYNDROMIC SURVEILLANCE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL DIAGNOSTIC LABS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL DIAGNOSTIC LABS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL DIAGNOSTIC LABS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL PUBLIC HEALTH AGENCIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL PUBLIC HEALTH AGENCIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 130. GLOBAL PUBLIC HEALTH AGENCIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL RESEARCH INSTITUTES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL RESEARCH INSTITUTES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 133. GLOBAL RESEARCH INSTITUTES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 135. ASIA-PACIFIC INFECTION SURVEILLANCE SOLUTION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 136. ASIA-PACIFIC INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 137. ASIA-PACIFIC INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 138. ASIA-PACIFIC INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 139. ASIA-PACIFIC INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 140. ASIA-PACIFIC INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY ARTIFICIAL INTELLIGENCE AND MACHINE LEARNING, 2018-2032 (USD MILLION)
  • TABLE 141. ASIA-PACIFIC INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY INFECTION TYPE MONITORED, 2018-2032 (USD MILLION)
  • TABLE 142. ASIA-PACIFIC INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 143. ASIA-PACIFIC INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)
  • TABLE 144. ASIA-PACIFIC INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY ON PREMISES, 2018-2032 (USD MILLION)
  • TABLE 145. ASIA-PACIFIC INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 146. ASIA-PACIFIC INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY INFECTION CONTROL & HAI SURVEILLANCE, 2018-2032 (USD MILLION)
  • TABLE 147. ASIA-PACIFIC INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY OUTBREAK MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 148. ASIA-PACIFIC INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 149. NORTH AMERICA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 150. NORTH AMERICA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 151. NORTH AMERICA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 152. NORTH AMERICA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 153. NORTH AMERICA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 154. NORTH AMERICA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY ARTIFICIAL INTELLIGENCE AND MACHINE LEARNING, 2018-2032 (USD MILLION)
  • TABLE 155. NORTH AMERICA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY INFECTION TYPE MONITORED, 2018-2032 (USD MILLION)
  • TABLE 156. NORTH AMERICA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 157. NORTH AMERICA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)
  • TABLE 158. NORTH AMERICA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY ON PREMISES, 2018-2032 (USD MILLION)
  • TABLE 159. NORTH AMERICA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 160. NORTH AMERICA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY INFECTION CONTROL & HAI SURVEILLANCE, 2018-2032 (USD MILLION)
  • TABLE 161. NORTH AMERICA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY OUTBREAK MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 162. NORTH AMERICA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 163. LATIN AMERICA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 164. LATIN AMERICA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 165. LATIN AMERICA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 166. LATIN AMERICA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 167. LATIN AMERICA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 168. LATIN AMERICA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY ARTIFICIAL INTELLIGENCE AND MACHINE LEARNING, 2018-2032 (USD MILLION)
  • TABLE 169. LATIN AMERICA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY INFECTION TYPE MONITORED, 2018-2032 (USD MILLION)
  • TABLE 170. LATIN AMERICA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 171. LATIN AMERICA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)
  • TABLE 172. LATIN AMERICA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY ON PREMISES, 2018-2032 (USD MILLION)
  • TABLE 173. LATIN AMERICA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 174. LATIN AMERICA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY INFECTION CONTROL & HAI SURVEILLANCE, 2018-2032 (USD MILLION)
  • TABLE 175. LATIN AMERICA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY OUTBREAK MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 176. LATIN AMERICA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 177. EUROPE INFECTION SURVEILLANCE SOLUTION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 178. EUROPE INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 179. EUROPE INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 180. EUROPE INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 181. EUROPE INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 182. EUROPE INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY ARTIFICIAL INTELLIGENCE AND MACHINE LEARNING, 2018-2032 (USD MILLION)
  • TABLE 183. EUROPE INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY INFECTION TYPE MONITORED, 2018-2032 (USD MILLION)
  • TABLE 184. EUROPE INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 185. EUROPE INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)
  • TABLE 186. EUROPE INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY ON PREMISES, 2018-2032 (USD MILLION)
  • TABLE 187. EUROPE INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 188. EUROPE INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY INFECTION CONTROL & HAI SURVEILLANCE, 2018-2032 (USD MILLION)
  • TABLE 189. EUROPE INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY OUTBREAK MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 190. EUROPE INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 191. MIDDLE EAST INFECTION SURVEILLANCE SOLUTION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 192. MIDDLE EAST INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 193. MIDDLE EAST INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 194. MIDDLE EAST INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 195. MIDDLE EAST INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 196. MIDDLE EAST INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY ARTIFICIAL INTELLIGENCE AND MACHINE LEARNING, 2018-2032 (USD MILLION)
  • TABLE 197. MIDDLE EAST INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY INFECTION TYPE MONITORED, 2018-2032 (USD MILLION)
  • TABLE 198. MIDDLE EAST INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 199. MIDDLE EAST INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)
  • TABLE 200. MIDDLE EAST INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY ON PREMISES, 2018-2032 (USD MILLION)
  • TABLE 201. MIDDLE EAST INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 202. MIDDLE EAST INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY INFECTION CONTROL & HAI SURVEILLANCE, 2018-2032 (USD MILLION)
  • TABLE 203. MIDDLE EAST INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY OUTBREAK MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 204. MIDDLE EAST INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 205. AFRICA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 206. AFRICA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 207. AFRICA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 208. AFRICA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 209. AFRICA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 210. AFRICA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY ARTIFICIAL INTELLIGENCE AND MACHINE LEARNING, 2018-2032 (USD MILLION)
  • TABLE 211. AFRICA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY INFECTION TYPE MONITORED, 2018-2032 (USD MILLION)
  • TABLE 212. AFRICA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 213. AFRICA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)
  • TABLE 214. AFRICA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY ON PREMISES, 2018-2032 (USD MILLION)
  • TABLE 215. AFRICA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 216. AFRICA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY INFECTION CONTROL & HAI SURVEILLANCE, 2018-2032 (USD MILLION)
  • TABLE 217. AFRICA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY OUTBREAK MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 218. AFRICA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 219. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 220. ASEAN INFECTION SURVEILLANCE SOLUTION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 221. ASEAN INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 222. ASEAN INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 223. ASEAN INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 224. ASEAN INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 225. ASEAN INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY ARTIFICIAL INTELLIGENCE AND MACHINE LEARNING, 2018-2032 (USD MILLION)
  • TABLE 226. ASEAN INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY INFECTION TYPE MONITORED, 2018-2032 (USD MILLION)
  • TABLE 227. ASEAN INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 228. ASEAN INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)
  • TABLE 229. ASEAN INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY ON PREMISES, 2018-2032 (USD MILLION)
  • TABLE 230. ASEAN INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 231. ASEAN INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY INFECTION CONTROL & HAI SURVEILLANCE, 2018-2032 (USD MILLION)
  • TABLE 232. ASEAN INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY OUTBREAK MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 233. ASEAN INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 234. GCC INFECTION SURVEILLANCE SOLUTION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 235. GCC INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 236. GCC INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 237. GCC INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 238. GCC INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 239. GCC INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY ARTIFICIAL INTELLIGENCE AND MACHINE LEARNING, 2018-2032 (USD MILLION)
  • TABLE 240. GCC INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY INFECTION TYPE MONITORED, 2018-2032 (USD MILLION)
  • TABLE 241. GCC INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 242. GCC INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)
  • TABLE 243. GCC INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY ON PREMISES, 2018-2032 (USD MILLION)
  • TABLE 244. GCC INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 245. GCC INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY INFECTION CONTROL & HAI SURVEILLANCE, 2018-2032 (USD MILLION)
  • TABLE 246. GCC INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY OUTBREAK MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 247. GCC INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 248. EUROPEAN UNION INFECTION SURVEILLANCE SOLUTION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 249. EUROPEAN UNION INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 250. EUROPEAN UNION INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 251. EUROPEAN UNION INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 252. EUROPEAN UNION INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 253. EUROPEAN UNION INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY ARTIFICIAL INTELLIGENCE AND MACHINE LEARNING, 2018-2032 (USD MILLION)
  • TABLE 254. EUROPEAN UNION INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY INFECTION TYPE MONITORED, 2018-2032 (USD MILLION)
  • TABLE 255. EUROPEAN UNION INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 256. EUROPEAN UNION INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)
  • TABLE 257. EUROPEAN UNION INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY ON PREMISES, 2018-2032 (USD MILLION)
  • TABLE 258. EUROPEAN UNION INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 259. EUROPEAN UNION INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY INFECTION CONTROL & HAI SURVEILLANCE, 2018-2032 (USD MILLION)
  • TABLE 260. EUROPEAN UNION INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY OUTBREAK MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 261. EUROPEAN UNION INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 262. BRICS INFECTION SURVEILLANCE SOLUTION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 263. BRICS INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 264. BRICS INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 265. BRICS INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 266. BRICS INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 267. BRICS INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY ARTIFICIAL INTELLIGENCE AND MACHINE LEARNING, 2018-2032 (USD MILLION)
  • TABLE 268. BRICS INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY INFECTION TYPE MONITORED, 2018-2032 (USD MILLION)
  • TABLE 269. BRICS INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 270. BRICS INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)
  • TABLE 271. BRICS INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY ON PREMISES, 2018-2032 (USD MILLION)
  • TABLE 272. BRICS INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 273. BRICS INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY INFECTION CONTROL & HAI SURVEILLANCE, 2018-2032 (USD MILLION)
  • TABLE 274. BRICS INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY OUTBREAK MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 275. BRICS INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 276. G7 INFECTION SURVEILLANCE SOLUTION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 277. G7 INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 278. G7 INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 279. G7 INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 280. G7 INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 281. G7 INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY ARTIFICIAL INTELLIGENCE AND MACHINE LEARNING, 2018-2032 (USD MILLION)
  • TABLE 282. G7 INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY INFECTION TYPE MONITORED, 2018-2032 (USD MILLION)
  • TABLE 283. G7 INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 284. G7 INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)
  • TABLE 285. G7 INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY ON PREMISES, 2018-2032 (USD MILLION)
  • TABLE 286. G7 INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 287. G7 INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY INFECTION CONTROL & HAI SURVEILLANCE, 2018-2032 (USD MILLION)
  • TABLE 288. G7 INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY OUTBREAK MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 289. G7 INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 290. NATO INFECTION SURVEILLANCE SOLUTION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 291. NATO INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 292. NATO INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 293. NATO INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 294. NATO INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 295. NATO INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY ARTIFICIAL INTELLIGENCE AND MACHINE LEARNING, 2018-2032 (USD MILLION)
  • TABLE 296. NATO INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY INFECTION TYPE MONITORED, 2018-2032 (USD MILLION)
  • TABLE 297. NATO INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 298. NATO INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)
  • TABLE 299. NATO INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY ON PREMISES, 2018-2032 (USD MILLION)
  • TABLE 300. NATO INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 301. NATO INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY INFECTION CONTROL & HAI SURVEILLANCE, 2018-2032 (USD MILLION)
  • TABLE 302. NATO INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY OUTBREAK MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 303. NATO INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 304. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 305. UNITED STATES INFECTION SURVEILLANCE SOLUTION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 306. UNITED STATES INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 307. UNITED STATES INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 308. UNITED STATES INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 309. UNITED STATES INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 310. UNITED STATES INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY ARTIFICIAL INTELLIGENCE AND MACHINE LEARNING, 2018-2032 (USD MILLION)
  • TABLE 311. UNITED STATES INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY INFECTION TYPE MONITORED, 2018-2032 (USD MILLION)
  • TABLE 312. UNITED STATES INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 313. UNITED STATES INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)
  • TABLE 314. UNITED STATES INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY ON PREMISES, 2018-2032 (USD MILLION)
  • TABLE 315. UNITED STATES INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 316. UNITED STATES INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY INFECTION CONTROL & HAI SURVEILLANCE, 2018-2032 (USD MILLION)
  • TABLE 317. UNITED STATES INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY OUTBREAK MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 318. UNITED STATES INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 319. CANADA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 320. CANADA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 321. CANADA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 322. CANADA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 323. CANADA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 324. CANADA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY ARTIFICIAL INTELLIGENCE AND MACHINE LEARNING, 2018-2032 (USD MILLION)
  • TABLE 325. CANADA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY INFECTION TYPE MONITORED, 2018-2032 (USD MILLION)
  • TABLE 326. CANADA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT MODE, 2018-2032 (USD MILLION)
  • TABLE 327. CANADA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)
  • TABLE 328. CANADA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY ON PREMISES, 2018-2032 (USD MILLION)
  • TABLE 329. CANADA INFECTION SU